Epidemiological community acquired pneumonia study
Organizational Data
- DRKS-ID:
- DRKS00005274
- Recruitment Status:
- Recruiting ongoing
- Date of registration in DRKS:
- 2013-09-11
- Last update in DRKS:
- 2013-09-11
- Registration type:
- Retrospective
Acronym/abbreviation of the study
CAPNETZ Study
URL of the study
http://www.capnetz.de/html/home
Brief summary in lay language
Long-term objectives of the basic research part are improvement of CAP-management with respect to therapy, diagnosis and prevention.
Brief summary in scientific language
Long-term objectives of the basic research part are improvement of CAP-management with respect to therapy, diagnosis and prevention to contribute to a better care of patients with pneumonia.
Health condition or problem studied
- Free text:
- CAP; Community Acquired Pneumonia; ambulant erworbenen Pneumonie;
- ICD10:
- J18 - Pneumonia, organism unspecified
- Healthy volunteers:
- No Entry
Interventions, Observational Groups
- Arm 1:
- Long-term objectives of the basic research part are improvement of CAP-management with respect to therapy, diagnosis and prevention to contribute to a better care of patients with pneumonia
Endpoints
- Primary outcome:
- Long-term objectives are improvement of CAP-management with respect to therapy, diagnosis and prevention
- Secondary outcome:
- to contribute to a better care of patients with pneumonia
Study Design
- Purpose:
- Treatment
- Retrospective/prospective:
- No Entry
- Study type:
- Non-interventional
- Longitudinal/cross-sectional:
- No Entry
- Study type non-interventional:
- Epidemiological study
Recruitment
- Recruitment Status:
- Recruiting ongoing
- Reason if recruiting stopped or withdrawn:
- No Entry
Recruitment Locations
- Recruitment countries:
-
- Denmark
- Germany
- Netherlands
- Switzerland
- Number of study centers:
- Multicenter study
- Recruitment location(s):
-
- University medical center CAPNETZ STIFTUNG Hannover
Recruitment period and number of participants
- Planned study start date:
- No Entry
- Actual study start date:
- 2002-10-01
- Planned study completion date:
- No Entry
- Actual Study Completion Date:
- No Entry
- Target Sample Size:
- 10000
- Final Sample Size:
- No Entry
Inclusion Criteria
- Sex:
- All
- Minimum Age:
- 18 Years
- Maximum Age:
- no maximum age
- Additional Inclusion Criteria:
- age ≥ 18, infiltrate on chest X-ray, further Inclusion criteria: cough or production of purulent sputum or pathologic lung auscultation (crackles) or fiver
Exclusion Criteria
hospital inpatient treatment within the last 28 days, Immune suppressed patients, immunosuppression
Addresses
Primary Sponsor
- Address:
- Universitätsklinikum Ulm, Institut für Medizinische Mikrobiologie und HygieneAlbert-Einstein-Allee 2389081 UlmGermany
- Telephone:
- No Entry
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
- Investigator Sponsored/Initiated Trial (IST/IIT):
- Yes
Contact for Scientific Queries
- Address:
- MUMC+Department of Respiratory MedicineProf. Dr. Gernot RohdePostbus 58006202 MaastrichtNetherlands
- Telephone:
- 0031-43387-6372
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Contact for Public Queries
- Address:
- Universitätsklinikum JenaProf. Dr. Mathias PletzErlanger Allee 10107743 JenaGermany
- Telephone:
- 03641 932 4650
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Principal Investigator
- Address:
- MUMC+Department of Respiratory MedicineProf. Dr. Gernot RohdePostbus 58006202 MaastrichtNetherlands
- Telephone:
- 0031-43387-6372
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Sources of Monetary or Material Support
Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)
- Address:
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt, GmbHIngolstädter Landstraße 185764 NeuherbergGermany
- Telephone:
- No Entry
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Ethics Committee
Address Ethics Committee
- Address:
- Ethik-Kommission der Otto-von-Guericke-Universität an der Medizinischen Fakultät und am Universitätsklinikum Magdeburg A.ö.R.Leipziger Str. 44 Haus 2839120 MagdeburgGermany
- Telephone:
- +49-391-6714314
- Fax:
- +49-391-67290185
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Vote of leading Ethics Committee
- Vote of leading Ethics Committee
- Date of ethics committee application:
- 2001-09-03
- Ethics committee number:
- 104/01
- Vote of the Ethics Committee:
- Approved
- Date of the vote:
- 2001-09-03
Further identification numbers
- Other primary registry ID:
- No Entry
- EudraCT Number:
- No Entry
IPD - Individual Participant Data
- Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
- No Entry
- IPD Sharing Plan:
- No Entry
Study protocol and other study documents
- Study protocols:
- No Entry
- Study abstract:
- No Entry
- Other study documents:
- No Entry
- Background literature:
- No Entry
- Related DRKS studies:
- No Entry
Publication of study results
- Planned publication:
- No Entry
- Publikationen/Studienergebnisse:
- Presentation, etiology and outcome of pneumonia in younger nursing home residents.
- Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study.
- Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study
- Community-acquired pneumonia in younger patients is an entity on its own
- Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study
- Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia
- How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.
- Influenza vaccination is associated with reduced severity of community-acquired pneumonia.
- Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
- Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
- Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors
- Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.
- Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).
- Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment.
- Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
- Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia.
- Antibiotic treatment of community acquired pneumonia varies widely across Germany.
- Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ
- CRB-65 predicts death from community-acquired pneumonia.
- Date of first publication of study results:
- No Entry
- DRKS entry published for the first time with results:
- No Entry
Basic reporting
- Basic Reporting / Results tables:
- No Entry
- Brief summary of results:
- No Entry